Handbook for Investors 08. Juni 2023 Handbook for Investors The handbook provides information on the most important aspects of Switzerland as a modern and innovative business and technology location. It co...
Tecnologie e settori svizzeri Settori chiave Le associazioni e le organizzazioni di settore, nel loro ruolo di partner della rete nazionale di Switzerland Global Enterprise (S-GE), assicuran...
Report 21. Juli 2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...
News 21. Juni 2021 Pharmaplan opens a branch in Visp In response to the investment surge in the pharmaceutical industry, the TTP Group is opening a new Pharmaplan office on the Visp biotechnology si...
News 10. Mai 2021 Lonza invests CHF 650 million in a new large-scale production facility in Visp Biopharmaceutical giant Lonza has announced expansion plans for next-generation mammalian manufacturing facilities on its Visp site. With an inve...
Technologien + Branchen Branchen Branchenverbände und Sektororganisationen stellen als Partner im nationalen Netzwerk von Switzerland Global Enterprise (S-GE) sicher, dass die In...
News 27. Apr. 2021 Lonza invests CHF 200 million in a new production facility in Visp Biopharmaceutical company Lonza will build a new manufacturing facility dedicated to small molecules at its site in Visp. The new investment amou...
News 09. Jan. 2024 Molecular Partners and Orano Med announce strategic partnership Molecular Partners and Orano Med are joining forces for the development of protein drugs known as DARPin therapeutics. The radioactive payloads o...
Success stories 15. Apr. 2020 Switzerland is an interesting playground for IBM to develop artificial intelligence IBM Switzerland This year's Swiss Biotech Report by the Swiss Biotech Association outlines a new decade - a decade in which Switzerland can rely on a compre...
Actualités 31. Okt. 2023 Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais Debiopharm Research & Manufacturing a annoncé un investissement de plus de CHF 30 millions dans l’agrandissement de son laboratoire de Martigny, ...
News 26. Juli 2023 LimmaTech Bio cooperating with GSK on vaccine development The biotechnology firm LimmaTech Biologics has concluded a license agreement with GlaxoSmithKline Biologicals (GSK). In this way, LimmaTech is se...
News 04. Jan. 2021 Zifo RnD Solutions coming to Basel Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo Switzerla...
Fact Sheet 04. Mai 2022 Advanced Manufacturing in Switzerland As a production location, Switzerland offers companies optimal conditions to optimize their manufacturing processes through increased efficiency ...
Fact Sheet 09. Juni 2022 Switzerland - a hub for personalized health The close collaboration between science and industry is unique in Switzerland: Companies in the life sciences sector benefit from fast technology...
Member of the Month 03. Febr. 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...
뉴스 02. Juni 2023 최신 연구에 따르면 유럽 바이오테크 기업의 20%가 스위스에 본사를 두고 있습니다 Press release IQVIA가 수행하고 최근 2023 스위스 바이오테크 보고서에 발표된 새로운 연구에 따르면 유럽 바이오테크 기업의 20%가 현재 스위스에 본사를 두고 있습니다. 또한 스위스 연방 정부, 주 및 지역의 작년 투자 유치 통계에 따르면 이러한 추세가 지속되고 있음을...
News 07. Dez. 2020 CSL Behring opens new manufacturing facility in Bern Leading global biotech company CSL Behring has recently inaugurated a new state-of-the-art immunoglobulin manufacturing plant in the Swiss canton...